Skip to main content

Market Overview

Mid-Day Market Update: Gold Plunges Over 4%; Pfenex Shares Spike Higher

Share:

Midway through trading Tuesday, the Dow traded up 0.97% to 28061.49 while the NASDAQ fell 0.19% to 10,947. The S&P also rose, gaining 0.35% to 3,372.07.

The U.S. has the highest number of coronavirus cases and deaths in the world, reporting a total of 5,094,560 cases with around 163,460 deaths. Brazil confirmed a total of over 3,057,470 COVID-19 cases with 101,750 deaths, while India reported a total of at least 2,268,670 confirmed cases and 45,250 deaths. In total, there were at least 20,092,850 cases of COVID-19 worldwide with over 736,250 deaths, according to data compiled by Johns Hopkins University.

Leading and Lagging Sectors

Energy shares gained 2.3% on Tuesday. Meanwhile, top gainers in the sector included Pacific Ethanol, Inc. (NASDAQ: PEIX), up 16%, and Golar LNG Limited (NASDAQ: GLNG), up 13%.

In trading on Tuesday, utilities shares fell by 1.4%.

Top Headline

SYSCO Corporation (NYSE: SYY) reported a narrower-than-expected loss for its second quarter.

Sysco posted a Q2 loss of $0.29 per share, narrower than analysts’ estimates for a loss of $0.30 per share. The company reported quarterly sales of $8.90 billion, missing expectations of $9.52 billion.

Equities Trading UP

Pfenex Inc. (NYSE: PFNX) shares shot up 66% to $12.71 after the company announced it will be acquired by Ligand for $12 per share in cash.

Shares of Eyenovia, Inc. (NASDAQ: EYEN) got a boost, shooting 41% to $5.12. Eyenovia and Arctic Vision reported an exclusive collaboration and license agreement to develop and commercialize MicroPine and MicroLine in Greater China and South Korea.

Kforce Inc. (NASDAQ: KFRC) shares were also up, gaining 29% to $41.08 after the company reported better-than-expected Q2 results and also issued strong Q3 guidance.

Equities Trading DOWN

Fulcrum Therapeutics Inc (NASDAQ: FULC) shares tumbled 45% to $9.41 after the company posted a Q2 loss of $0.66 per share and announced interim analysis data from its ReDUX4 trial in facioscapulohumeral muscular dystrophy.

Shares of Mesoblast limited (NASDAQ: MESO) were down 33% to $11.60. The company has an FDA Advisory Committee meeting on August 13th to review data supporting its Biologics License Application for approval of RYONCIL for children.

Fennec Pharmaceuticals Inc (NASDAQ: FENC) was down, falling 34% to $6.68 after the company announced it has received a response from the FDA for PEDMARK NDA indicating identified deficiencies with the facility of the drug product manufacturer, which require resolution prior to PEDMARK approval.

Commodities

In commodity news, oil traded up 0.7% to $42.25, while gold traded down 4.2% to $1,953.70.

Silver traded down 7.1% Tuesday to $27.19, while copper rose 0.1% to $2.8655.

Euro zone

European shares were higher today. The eurozone’s STOXX 600 rose 1.68%, the Spanish Ibex Index rose 2.97%, while Italy’s FTSE MIB Index gained 2.84%. Meanwhile, the German DAX 30 gained 2.04%, French CAC 40 rose 2.41% and UK shares rose 1.71%.

Economics

The NFIB small business optimism index declined to 98.8 in July versus 100.6 in the prior month.

The Producer Price Index increased 0.6% in July following a 0.2% drop in June.

The Treasury will auction 3-year notes at 1:00 p.m. ET.

 

Related Articles (FENC + EYEN)

View Comments and Join the Discussion!

Posted-In: Earnings News Penny Stocks Eurozone Commodities Global Intraday Update Markets

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com